Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Glen Clova Scientific Logo
Glen Clova Scientific Growth Score
80
CB Rank
68169
Heat Score
27
Glen Clova Scientific is a company that developing a new gneration of active biological drugs.
Founded
obfuscation
PrivateSeed Scotland, Indiana, United States1-10 glenclovascientific.com
Biopharma
Biotechnology
Hospital
Overview

Glen Clova Scientific
Total Funding
obfuscation
Growth Score
80
Heat Score
27

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score80
-5 pts
in past quarter
Heat Score 27
-11 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Glen Clova Scientific

CB Rank
68169
Glen Clova Scientific is a company that developing a new gneration of active biological drugs.
Founded
obfuscation
PrivateSeed Scotland, Indiana, United States1-10 glenclovascientific.com
Biopharma
Biotechnology
Hospital

Funding Rounds

Seed
OBF
in
obfuscation

Key People

Details

Legal Name Glen Clova Scientific Ltd.
Operating Status Active
Company Type For Profit
Founders  John Foerster, Steven Powell
About the Company
Glen Clova Scientific is a company that developing a new gneration of active biological drugs.
Contact Email info@glenclovascientific.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

Active Biologic Drugs
Glen Clova Scientific is developing a new class of biologic drugs that reduce dosing frequency and drug quantity per dose, aiming to improve pharmaco-economics and treatment accessibility.
GCS001
A preclinical drug candidate targeting senile pruritus, atopic dermatitis, and prurigo, developed from Glen Clova's proprietary platform.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Glen Clova Scientific Logo
Seed Round - Glen Clova Scientific
4
obfuscation
Norcliffe CapitalSeed
obfuscation
Seed Round - Glen Clova Scientific Logo
Seed Round - Glen Clova Scientific
4
obfuscation
Norcliffe CapitalSeed
obfuscation
Seed Round - Glen Clova Scientific Logo
Seed Round - Glen Clova Scientific
4
obfuscation
Norcliffe CapitalSeed
obfuscation
Seed Round - Glen Clova Scientific Logo
Seed Round - Glen Clova Scientific
4
obfuscation
Norcliffe CapitalSeed
obfuscation
Seed Round - Glen Clova Scientific Logo
Seed Round - Glen Clova Scientific
4
obfuscation
Norcliffe CapitalSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Glen Clova Scientific Logo
Seed Round - Glen Clova Scientific
4
obfuscation
Norcliffe CapitalSeed
obfuscation
Seed Round - Glen Clova Scientific Logo
Seed Round - Glen Clova Scientific
4
obfuscation
Norcliffe CapitalSeed
obfuscation
Seed Round - Glen Clova Scientific Logo
Seed Round - Glen Clova Scientific
4
obfuscation
Norcliffe CapitalSeed
obfuscation
Seed Round - Glen Clova Scientific Logo
Seed Round - Glen Clova Scientific
4
obfuscation
Norcliffe CapitalSeed
obfuscation
Seed Round - Glen Clova Scientific Logo
Seed Round - Glen Clova Scientific
4
obfuscation
Norcliffe CapitalSeed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1

Employee Profiles

News

News and Press

News•Oct 9, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,419

Active Website Tech Count

3Glen Clova Scientific is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Euro.
Sub-Organizations
Frequently Asked Questions

Where is Glen Clova Scientific's headquarters? Glen Clova Scientific is located in Scotland, Indiana, United States.Who invested in Glen Clova Scientific? Glen Clova Scientific has 4 investors including Norcliffe Capital and  Scottish Enterprise.When was the last funding round for Glen Clova Scientific? Glen Clova Scientific closed its last funding round on
obfuscation
from a Seed round.Who are Glen Clova Scientific's competitors? Alternatives and possible competitors to Glen Clova Scientific may include Sanofi, AstraZeneca, and  Galderma.How much funding has Glen Clova Scientific raised to date? Glen Clova Scientific has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3120884 1)
|